Mifepristone / Misoprostol

Key facts

Active substance
  • mifepristone
  • Misoprostol
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/156/2009
PIP number
Mifepristone / Misoprostol
Pharmaceutical form(s)
Tablets
Condition(s) / indication(s)
Medical Abortion
Route(s) of administration
  • Oral use
  • Vaginal use
Contact for public enquiries
Sun Pharmaceutical Industries Europe B.V.
E-mail: secretary.netherlands@sunpharma-europe.com
Country: Netherlands
Phone: +31 235685501
Fax: +31 235685505
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating